The Global Burden of Cancer 2013
- PMID: 26181261
- PMCID: PMC4500822
- DOI: 10.1001/jamaoncol.2015.0735
The Global Burden of Cancer 2013
Erratum in
-
Errors in Author Names.JAMA Oncol. 2015 Aug;1(5):690. doi: 10.1001/jamaoncol.2015.2892. JAMA Oncol. 2015. PMID: 26270254 No abstract available.
Abstract
Importance: Cancer is among the leading causes of death worldwide. Current estimates of cancer burden in individual countries and regions are necessary to inform local cancer control strategies.
Objective: To estimate mortality, incidence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) for 28 cancers in 188 countries by sex from 1990 to 2013.
Evidence review: The general methodology of the Global Burden of Disease (GBD) 2013 study was used. Cancer registries were the source for cancer incidence data as well as mortality incidence (MI) ratios. Sources for cause of death data include vital registration system data, verbal autopsy studies, and other sources. The MI ratios were used to transform incidence data to mortality estimates and cause of death estimates to incidence estimates. Cancer prevalence was estimated using MI ratios as surrogates for survival data; YLDs were calculated by multiplying prevalence estimates with disability weights, which were derived from population-based surveys; YLLs were computed by multiplying the number of estimated cancer deaths at each age with a reference life expectancy; and DALYs were calculated as the sum of YLDs and YLLs.
Findings: In 2013 there were 14.9 million incident cancer cases, 8.2 million deaths, and 196.3 million DALYs. Prostate cancer was the leading cause for cancer incidence (1.4 million) for men and breast cancer for women (1.8 million). Tracheal, bronchus, and lung (TBL) cancer was the leading cause for cancer death in men and women, with 1.6 million deaths. For men, TBL cancer was the leading cause of DALYs (24.9 million). For women, breast cancer was the leading cause of DALYs (13.1 million). Age-standardized incidence rates (ASIRs) per 100 000 and age-standardized death rates (ASDRs) per 100 000 for both sexes in 2013 were higher in developing vs developed countries for stomach cancer (ASIR, 17 vs 14; ASDR, 15 vs 11), liver cancer (ASIR, 15 vs 7; ASDR, 16 vs 7), esophageal cancer (ASIR, 9 vs 4; ASDR, 9 vs 4), cervical cancer (ASIR, 8 vs 5; ASDR, 4 vs 2), lip and oral cavity cancer (ASIR, 7 vs 6; ASDR, 2 vs 2), and nasopharyngeal cancer (ASIR, 1.5 vs 0.4; ASDR, 1.2 vs 0.3). Between 1990 and 2013, ASIRs for all cancers combined (except nonmelanoma skin cancer and Kaposi sarcoma) increased by more than 10% in 113 countries and decreased by more than 10% in 12 of 188 countries.
Conclusions and relevance: Cancer poses a major threat to public health worldwide, and incidence rates have increased in most countries since 1990. The trend is a particular threat to developing nations with health systems that are ill-equipped to deal with complex and expensive cancer treatments. The annual update on the Global Burden of Cancer will provide all stakeholders with timely estimates to guide policy efforts in cancer prevention, screening, treatment, and palliation.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4500822/bin/emss-64123-f0001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4500822/bin/emss-64123-f0002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4500822/bin/emss-64123-f0003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4500822/bin/emss-64123-f0004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4500822/bin/emss-64123-f0005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4500822/bin/emss-64123-f0006.gif)
![Figure 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4500822/bin/emss-64123-f0007.gif)
![Figure 8](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4500822/bin/emss-64123-f0008.gif)
![Figure 9](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4500822/bin/emss-64123-f0009.gif)
![Figure 10](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4500822/bin/emss-64123-f0010.gif)
![Figure 11](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4500822/bin/emss-64123-f0011.gif)
![Figure 12](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4500822/bin/emss-64123-f0012.gif)
![Figure 13](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4500822/bin/emss-64123-f0013.gif)
![Figure 14](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4500822/bin/emss-64123-f0014.gif)
![Figure 15](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4500822/bin/emss-64123-f0015.gif)
Comment in
-
Novel Methods for Measuring Global Cancer Burden: Implications for Global Cancer Control.JAMA Oncol. 2015 Jul;1(4):425-7. doi: 10.1001/jamaoncol.2015.1426. JAMA Oncol. 2015. PMID: 26181245 No abstract available.
-
Risk factors: What do breast and CRC cancers and MS have in common?Nat Rev Clin Oncol. 2015 Oct;12(10):569-70. doi: 10.1038/nrclinonc.2015.154. Epub 2015 Sep 15. Nat Rev Clin Oncol. 2015. PMID: 26370607 No abstract available.
-
Effect of the coronavirus disease pandemic on bronchoscopic diagnosis of lung cancer in a provincial city in Japan.J Cardiothorac Surg. 2021 Apr 28;16(1):115. doi: 10.1186/s13019-021-01501-2. J Cardiothorac Surg. 2021. PMID: 33910601 Free PMC article. No abstract available.
Similar articles
-
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17. Lancet. 2024. PMID: 38642570 Free PMC article.
-
The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019.Lancet Oncol. 2022 Jan;23(1):27-52. doi: 10.1016/S1470-2045(21)00581-7. Epub 2021 Dec 3. Lancet Oncol. 2022. PMID: 34871551 Free PMC article.
-
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.JAMA Oncol. 2017 Apr 1;3(4):524-548. doi: 10.1001/jamaoncol.2016.5688. JAMA Oncol. 2017. PMID: 27918777 Free PMC article.
-
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Lancet. 2015 Aug 22;386(9995):743-800. doi: 10.1016/S0140-6736(15)60692-4. Epub 2015 Jun 7. Lancet. 2015. PMID: 26063472 Free PMC article. Review.
-
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.Lancet. 2013 Nov 9;382(9904):1575-86. doi: 10.1016/S0140-6736(13)61611-6. Epub 2013 Aug 29. Lancet. 2013. PMID: 23993280 Review.
Cited by
-
Efficacy and safety of robotic radical hysterectomy in cervical cancer compared with laparoscopic radical hysterectomy: a meta-analysis.Front Oncol. 2024 May 15;14:1303165. doi: 10.3389/fonc.2024.1303165. eCollection 2024. Front Oncol. 2024. PMID: 38812787 Free PMC article.
-
Long-term prognosis after endoscopic submucosal dissection for esophageal cancer in older adult patients.BMC Gastroenterol. 2024 May 14;24(1):164. doi: 10.1186/s12876-024-03234-7. BMC Gastroenterol. 2024. PMID: 38745162 Free PMC article.
-
Spatiotemporal Distribution, Time to Treatment Outcome Clustering and Determinants of Esophageal Cancer in Ethiopia, a Scoping Study.Cancer Control. 2024 Jan-Dec;31:10732748241251712. doi: 10.1177/10732748241251712. Cancer Control. 2024. PMID: 38716644 Free PMC article. Review.
-
Correlation between socioeconomic indices and epidemiological indices of thyroid cancer from 1990 to 2019 year: a global ecologic study.BMC Cancer. 2024 Apr 15;24(1):467. doi: 10.1186/s12885-024-12176-y. BMC Cancer. 2024. PMID: 38622568 Free PMC article.
-
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging.Cancers (Basel). 2024 Mar 30;16(7):1364. doi: 10.3390/cancers16071364. Cancers (Basel). 2024. PMID: 38611042 Free PMC article. Review.
References
-
- Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–2128. published correction appears in Lancet. 2013;381(9867):628. - PMC - PubMed
-
- Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997;349(9061):1269–1276. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical